Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health HIMS.
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 9 options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 55%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $26,000, and 8, calls, for a total amount of $929,618.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $19.0 for Hims & Hers Health over the recent three months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Hims & Hers Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims & Hers Health's whale trades within a strike price range from $10.0 to $19.0 in the last 30 days.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | TRADE | BULLISH | 01/17/25 | $15.00 | $515.5K | 5.1K | 1 |
| HIMS | CALL | TRADE | BULLISH | 07/19/24 | $15.00 | $185.5K | 1.2K | 0 |
| HIMS | CALL | TRADE | BULLISH | 01/17/25 | $15.00 | $47.5K | 5.1K | 1.5K |
| HIMS | CALL | SWEEP | BULLISH | 05/17/24 | $19.00 | $42.3K | 347 | 2 |
| HIMS | CALL | SWEEP | BEARISH | 04/19/24 | $16.00 | $37.5K | 1.6K | 951 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Having examined the options trading patterns of Hims & Hers Health, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Hims & Hers Health's Current Market Status
- Currently trading with a volume of 2,724,818, the HIMS's price is up by 0.58%, now at $15.73.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 47 days.
Professional Analyst Ratings for Hims & Hers Health
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $13.4.
- An analyst from Leerink Partners downgraded its action to Market Perform with a price target of $10.
- An analyst from Citigroup persists with their Buy rating on Hims & Hers Health, maintaining a target price of $16.
- An analyst from Truist Securities persists with their Hold rating on Hims & Hers Health, maintaining a target price of $13.
- An analyst from Guggenheim persists with their Buy rating on Hims & Hers Health, maintaining a target price of $17.
- An analyst from Piper Sandler has decided to maintain their Neutral rating on Hims & Hers Health, which currently sits at a price target of $11.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
